Resignation will ease the pain of Merck investors
115343
WHAT a pill Vioxx turned out to be for Merck. Between 50 cents and 60 cents a share were lopped off expected earnings this year after the US pharmaceutical giant gave up defending its painkiller in public
686772
Merck &amp; Co. shares fell as much as 7 percent to their lowest level in more than eight years after the Wall Street Journal said the drugmaker tried for years to stop safety concerns from hurting sales of its Vioxx painkiller.
689528
By Tom Walker, The Atlanta Journal-Constitution  Dec. 7--A top-level shake-up at Yahoo and a disappointing earnings  forecast by Merck & Co. gave investors an excuse Wednesday to sell and take  some profits off the table from the market's recent rally. All the major stock  indexes fell.
769773
TRENTON, N.J. -- Shares of drug maker Merck &amp; Co. dropped 2.5 percent in heavy trading yesterday, a day after medical journal reports offered fresh ammunition to patients suing over its withdrawn painkiller Vioxx.
316374
Merck &amp; Co&#39;s decision to stop selling the painkiller Vioxx, one of its most profitable drugs, could hardly have come at a worse time for the company.
526962
As worries for its anemia drugs abate, investors will start to worry about Merck and Novartis.
646011
Drugmaker Merck &amp; Co., under financial siege since pulling its top painkiller Vioxx off the market in September, said Monday it has adopted a plan that
233794
Merck & Co Inc. Thursday pulled its  arthritis drug Vioxx off the market because it increases the  risk of heart attack and stroke, a move that sent its shares  plunging, erasing $25 billion of its market value.
538571
The Wall Street Journal reports Merck &amp; Co. of Whitehouse Station, NJ, has begun hunting for a new chief executive officer. The move comes amid a string of bad news at the drug maker, including its recent
57265
Merck &amp; Co.&#39;s decision to pull its Vioxx anti-arthritis drug from the markets due to severe side effects left pharmaceutical sector mixed Thursday.
575614
Merck and Schering report bad news, but how much will it affect sales?
93237
Merck & Co. Inc. MRK.N, reeling from  the recent withdrawal of its Vioxx arthritis drug, on Wednesday  said 2005 earnings will decline to levels below Wall Street  expectations, the third straight year of lower results.
210616
Merck & Co. Inc., reeling from the recent withdrawal of its Vioxx arthritis drug, said Wednesday it expects 2005 earnings of &#36;2.42 to &#36;2.52 a share -- a decline from expected 2004 results.
334636
With its stock plunging, the drug giant Merck has adopted a plan that could give its top executives big bonuses if the company is taken over.
515664
Pharmaceutical giant Merck &amp; Co., under siege over revenues lost since it recalled arthritis drug Vioxx, will have cut about 5,100 jobs by year&#39;s end, 700 more than first planned, and will slash costs by $2.4 billion over four years, chairman and CEO
328918
Merck, the US pharmaceutical giant forced to withdraw its Vioxx painkiller last year, has seen a drop in profits and had to add to its legal reserves.
430514
Merck & Co. Inc. has adopted a  severance benefits plan aimed at protecting key managers in the  event the company is taken over -- a growing possibility since  the withdrawal of arthritis drug Vioxx sent shares tumbling.